Owlet, Inc. (OWLT)
USD 4.46
(-4.9%)
USD 4.46
(-4.9%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -32.9 Million USD | 58.51% |
| 2022 | -79.29 Million USD | 19.23% |
| 2021 | -98.16 Million USD | -833.06% |
| 2020 | -10.52 Million USD | 41.06% |
| 2019 | -17.85 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.14 Million USD | -135.03% |
| 2024 Q1 | 3.27 Million USD | 147.45% |
| 2023 Q3 | -6.96 Million USD | 17.8% |
| 2023 FY | -32.9 Million USD | 58.51% |
| 2023 Q4 | -6.9 Million USD | 0.86% |
| 2023 Q2 | -8.46 Million USD | 32.55% |
| 2023 Q1 | -12.55 Million USD | 35.63% |
| 2022 Q4 | -19.49 Million USD | -0.71% |
| 2022 Q3 | -19.36 Million USD | -65.12% |
| 2022 Q1 | -28.75 Million USD | -19.33% |
| 2022 FY | -79.29 Million USD | 19.23% |
| 2022 Q2 | -11.72 Million USD | 59.23% |
| 2021 Q1 | -7.85 Million USD | -35.51% |
| 2021 Q4 | -24.1 Million USD | 30.06% |
| 2021 Q3 | -34.45 Million USD | -545.85% |
| 2021 FY | -98.16 Million USD | -833.06% |
| 2021 Q2 | -5.33 Million USD | 32.1% |
| 2020 Q1 | -2.12 Million USD | 0.0% |
| 2020 Q4 | -5.79 Million USD | -286.28% |
| 2020 Q3 | -1.5 Million USD | -37.2% |
| 2020 Q2 | -1.09 Million USD | 48.59% |
| 2020 FY | -10.52 Million USD | 41.06% |
| 2019 FY | -17.85 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 100.575% |
| Allurion Technologies Inc. | -82.3 Million USD | 60.025% |
| Artivion, Inc. | -30.69 Million USD | -7.204% |
| Avanos Medical, Inc. | -61.8 Million USD | 46.762% |
| Butterfly Network, Inc. | -133.69 Million USD | 75.392% |
| Butterfly Network, Inc. | -133.69 Million USD | 75.392% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 94.838% |
| Boston Scientific Corporation | 1.59 Billion USD | 102.065% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | -124.274% |
| CONMED Corporation | 64.45 Million USD | 151.042% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 102.346% |
| Paragon 28, Inc. | -47.84 Million USD | 31.228% |
| Glaukos Corporation | -134.66 Million USD | 75.568% |
| Globus Medical, Inc. | 122.87 Million USD | 126.776% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | -55.538% |
| Integer Holdings Corporation | 90.65 Million USD | 136.295% |
| Medtronic plc | 3.67 Billion USD | 100.895% |
| Nevro Corp. | -92.21 Million USD | 64.321% |
| Penumbra, Inc. | 90.95 Million USD | 136.173% |
| Vicarious Surgical Inc. | -71.07 Million USD | 53.707% |
| Smith & Nephew plc | 263 Million USD | 112.51% |
| Sonendo, Inc. | -60.91 Million USD | 45.992% |
| STERIS plc | 378.23 Million USD | 108.698% |
| Stryker Corporation | 3.16 Billion USD | 101.04% |
| Vapotherm, Inc. | -58.19 Million USD | 43.462% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 103.213% |